News Focus
News Focus
icon url

md1225

11/25/16 8:43 AM

#85094 RE: hankmanhub #85093

That was my hope also but this is GBM cancer.... this trial is reading out 11/16.
And yes if data is favorable the company will be applying for FDA approval in 2017...
icon url

HappyLibrarian

11/25/16 9:14 AM

#85096 RE: hankmanhub #85093

In theory you're right but in practice we will reach the point of diminishing returns especially since a reverse split and other adverse outcomes for shareholders becomes more likely the longer there is a delay.

But the theory that the longer the wait, the better rests on conventional wisdom and conventional wisdom may not apply to a trial that has gone through so many overhauls, including I might remind you, a screening halt that never ended!

Besides, if more delays are so great, how come the closest thing to an official explanation to that effect comes from a heavily disputed video from Dr. Linda Liau that was pulled down?

Is it not reasonable for NWBO at say it's looming shareholder's meeting to explain what the failure of the trial to conclude means for shareholders?